Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter
Authors:
- Sandip K. MishraSMSandip K. Mishra
- Vivek M. RangnekarVRVivek M. Rangnekar
- Ana M. TariATAna M. Tari
- Rakesh KumarRKRakesh Kumar
- Gabriel Lopez-BeresteinGLGabriel Lopez-Berestein
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (22) , 19995-20005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancerOncogene, 2001
- Par4 is a coactivator for a splice isoform–specific transcriptional activation domain in WT1Genes & Development, 2001
- A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma CellsJournal of Biological Chemistry, 2000
- Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosisOncogene, 1999
- Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4Oncogene, 1999
- The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) LymphomasJournal of Biological Chemistry, 1997
- A License to KillCell, 1996
- Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cellsAnti-Cancer Drugs, 1996
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984